sep 15, 2016 - FDA convened a joint meeting of the Anesthetic
and Analgesic Drug Products Advisory
Committee, the Drug Safety and Risk
Management Advisory Committee, and the
Pediatric Advisory Committee to discuss the
appropriate development plans for establishing
the safety and efficacy of prescription opioid
analgesics for pediatric patients.
Added to timeline:
Opioids and the FDA
Date: